Scientists: HPV vaccination reduces the risk of preterm birth
An international team of scientists has conducted a large-scale study on the impact of the human papillomavirus (HPV) vaccine on women's health. The results of the work showed that timely immunization can not only protect against dangerous diseases but also have a positive effect on the course of future pregnancies.
According to experts, women who were vaccinated before becoming pregnant face complications less frequently. Specifically, the risk of preterm birth, which occurs before the 37th week, was 5% lower among the vaccinated study participants. This is an important discovery for modern medicine, as preterm birth is often a cause of serious health problems in newborns.
Human papillomavirus is one of the most common infections in the world. Doctors have long recommended vaccination for the prevention of cervical cancer and other oncological diseases. The new study adds to the list of the vaccine's benefits, highlighting the importance of preventive measures for women's reproductive health.
Specialists note that vaccination is most effective if it is administered before the start of sexual activity. However, even at a more mature age, the vaccine helps the body develop the necessary immunity. In Russia, HPV vaccination is available in many private and public medical centers, and doctors urge women to be more attentive to their health.
Thus, the results of the study confirm that taking care of one's health in advance helps to avoid many risks in the future. Scientists plan to continue their observations to study in more detail the effect of the vaccine on fetal development and the general health of the mother.